YangXue QingNao Wan and Silibinin Capsules, the Two Chinese Medicines, Attenuate Cognitive Impairment in Aged LDLR (+/-) Golden Syrian Hamsters Involving Protection of Blood Brain Barrier

The purpose of the study was to explore the effect and the underlying mechanism of YangXue QingNao Wan (YXQNW) and Silibinin Capsules (SC), the two Chinese medicines, on cognitive impairment in older people with familial hyperlipidaemia. Fourteen month-old female LDLR (+/-) golden Syrian hamsters we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Physiol
Autors principals: Gu, You-Yu, Huang, Ping, Li, Quan, Liu, Yu-Ying, Liu, George, Wang, Yu-Hui, Yi, Ming, Yan, Li, Wei, Xiao-Hong, Yang, Lei, Hu, Bai-He, Zhao, Xin-Rong, Chang, Xin, Sun, Kai, Pan, Chun-Shui, Cui, Yuan-Chen, Chen, Qing-Fang, Wang, Chuan-She, Fan, Jing-Yu, Ma, Zhi-Zhong, Han, Jing-Yan
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Physiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992341/
https://ncbi.nlm.nih.gov/pubmed/29910744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2018.00658
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars